Icosavax Inc   (ICVX)
Other Ticker:  


Icosavax Inc

ICVX's Financial Statements and Analysis

Icosavax Inc narrowed III. Quarter net loss per share of $-0.55 compare to net loss per share of $-1.30 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.57 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.55 $  0 Mill
$+0.75     $-2M    

Icosavax Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.

Icosavax Inc is Expected to report next financial results on March 29, 2023.

More on ICVX's Income Statement

Icosavax Inc 's in III. Quarter recorded net loss of $-21.976 million, an improvement compare to net loss of $-34.386 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-22.636 million realized in previous quarter.

More on ICVX's Growth

In III. Quarter company's net cash and cash equivalents decreased by $-44 million, capital expenditures fell by 26,266.67%, to $-4 millions compare to same quarter a year ago and fell by 13.45% from II. Quarter (Jun 30 2022).

More on ICVX's Cash flow Statement

Icosavax Inc does not pay out common stock dividend.

In trailing twelve-month period Icosavax Inc payed $ -1.65 cash per share, on a free-cash flow basis .